New pro-oxidant supplement shows promise in slowing prostate cancer progression

Prostate cancer is a quiet killer. In most men, it’s treatable. However, in some cases, it resists all known therapies and turns extremely deadly.

Blood test may help identify patients at risk for transthyretin amyloid cardiomyopathy

A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone

July 29, 2023

New smartphone attachment could enable low-cost neurological screening for all

Engineers at the University of California San Diego have developed a smartphone attachment that could enable people to screen for a variety of neurological conditions,

October 25, 2023

If you’re poor, fertility treatment can be out of reach

Mary Delgado’s first pregnancy went according to plan, but when she tried to get pregnant again seven years later, nothing happened. After 10 months, Delgado,

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.